Outbreak of an extensively resistant strain of <em>Pseudomonas aeruginosa</em> in the US
DOI:
https://doi.org/10.31646/gbio.212Keywords:
antimicrobial resistance, pseudomonas aeruginosa, outbreak, eyedrop, disease surveillanceAbstract
In November 2022, the United States (US) Centers for Disease Control and Prevention (CDC) requested information regarding cases of Pseudomonas aeruginosa eye infections. As of March 2023, there have been 68 cases and three deaths associated with the outbreak, with a nationwide recall of ‘Ezricare Artificial Tears’ eyedrops issued on 2 February 2023.
Published
2023-04-13
How to Cite
Chen, R., & Quigley, A. (2023). Outbreak of an extensively resistant strain of <em>Pseudomonas aeruginosa</em> in the US. Global Biosecurity, 5(1). https://doi.org/10.31646/gbio.212
Issue
Section
Watching Briefs
License
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Received 2023-03-28
Accepted 2023-04-10
Published 2023-04-13
Accepted 2023-04-10
Published 2023-04-13
